These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice. Mines MA; Jope RS Cell Signal; 2012 Jul; 24(7):1398-405. PubMed ID: 22434044 [TBL] [Abstract][Full Text] [Related]
4. Functional significance of glycogen synthase kinase-3 regulation by serotonin. Polter AM; Yang S; Jope RS; Li X Cell Signal; 2012 Jan; 24(1):265-71. PubMed ID: 21946431 [TBL] [Abstract][Full Text] [Related]
5. Physiological and pathological changes in glucose regulate brain Akt and glycogen synthase kinase-3. Clodfelder-Miller B; De Sarno P; Zmijewska AA; Song L; Jope RS J Biol Chem; 2005 Dec; 280(48):39723-31. PubMed ID: 16179343 [TBL] [Abstract][Full Text] [Related]
6. Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine. Roh MS; Eom TY; Zmijewska AA; De Sarno P; Roth KA; Jope RS Biol Psychiatry; 2005 Feb; 57(3):278-86. PubMed ID: 15691529 [TBL] [Abstract][Full Text] [Related]
7. Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics. Li X; Rosborough KM; Friedman AB; Zhu W; Roth KA Int J Neuropsychopharmacol; 2007 Feb; 10(1):7-19. PubMed ID: 16672106 [TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels. Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622 [TBL] [Abstract][Full Text] [Related]
9. Regulation of Akt and glycogen synthase kinase-3 beta phosphorylation by sodium valproate and lithium. De Sarno P; Li X; Jope RS Neuropharmacology; 2002 Dec; 43(7):1158-64. PubMed ID: 12504922 [TBL] [Abstract][Full Text] [Related]
10. Anesthesia and post-mortem interval profoundly influence the regulatory serine phosphorylation of glycogen synthase kinase-3 in mouse brain. Li X; Friedman AB; Roh MS; Jope RS J Neurochem; 2005 Feb; 92(3):701-4. PubMed ID: 15659239 [TBL] [Abstract][Full Text] [Related]
11. Ketamine-induced inhibition of glycogen synthase kinase-3 contributes to the augmentation of α-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA) receptor signaling. Beurel E; Grieco SF; Amadei C; Downey K; Jope RS Bipolar Disord; 2016 Sep; 18(6):473-480. PubMed ID: 27687706 [TBL] [Abstract][Full Text] [Related]
12. Localized changes to glycogen synthase kinase-3 and collapsin response mediator protein-2 in the Huntington's disease affected brain. Lim NK; Hung LW; Pang TY; Mclean CA; Liddell JR; Hilton JB; Li QX; White AR; Hannan AJ; Crouch PJ Hum Mol Genet; 2014 Aug; 23(15):4051-63. PubMed ID: 24634145 [TBL] [Abstract][Full Text] [Related]
13. Growth factor withdrawal from primary human erythroid progenitors induces apoptosis through a pathway involving glycogen synthase kinase-3 and Bax. Somervaille TC; Linch DC; Khwaja A Blood; 2001 Sep; 98(5):1374-81. PubMed ID: 11520785 [TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase 3 beta is a natural activator of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 1 (MEKK1). Kim JW; Lee JE; Kim MJ; Cho EG; Cho SG; Choi EJ J Biol Chem; 2003 Apr; 278(16):13995-4001. PubMed ID: 12584189 [TBL] [Abstract][Full Text] [Related]
15. Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes. Montori-Grau M; Tarrats N; Osorio-Conles O; Orozco A; Serrano-Marco L; Vázquez-Carrera M; Gómez-Foix AM Cell Signal; 2013 May; 25(5):1318-27. PubMed ID: 23453973 [TBL] [Abstract][Full Text] [Related]
16. Early undernutrition increases glycogen content and reduces the activated forms of GSK3, AMPK, p38 MAPK, and JNK in the cerebral cortex of suckling rats. Lizárraga-Mollinedo E; Fernández-Millán E; de Miguel-Santos L; Martínez-Honduvilla CJ; Alvarez C; Escrivá F J Neurochem; 2010 Jan; 112(1):123-33. PubMed ID: 19840222 [TBL] [Abstract][Full Text] [Related]
17. Deficiency in the inhibitory serine-phosphorylation of glycogen synthase kinase-3 increases sensitivity to mood disturbances. Polter A; Beurel E; Yang S; Garner R; Song L; Miller CA; Sweatt JD; McMahon L; Bartolucci AA; Li X; Jope RS Neuropsychopharmacology; 2010 Jul; 35(8):1761-74. PubMed ID: 20357757 [TBL] [Abstract][Full Text] [Related]